白内障の予防剤および治療剤、並びに、これらを製造するための、ＤＮＡ損傷に応答するシグナル伝達経路を阻害する阻害剤の使用 - National University Corporation Fukui University

Title:

白内障の予防剤および治療剤、並びに、これらを製造するための、ＤＮＡ損傷に応答するシグナル伝達経路を阻害する阻害剤の使用

Document Type and Number:

Japanese Patent JP7007559

Kind Code:

B2

Abstract:

To provide an agent for preventing and treating cataracts having a different action mechanism from the conventional art, and use of an inhibitor that inhibits a signaling route responding to DNA damage for producing the same.SOLUTION: An agent for preventing and treating cataracts contains an inhibitor that inhibits a signaling route responding to DNA damage, as an active ingredient.SELECTED DRAWING: None

More Like This:

WO/2022/271935	ERK1/2 INHIBITOR COMBINATION THERAPY
WO/2021/178525	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CANCER USING DEUBIQUITINASE INHIBITORS

Inventors:

Masaya Oki
Fumito Kaneda
▲高▼村佳弘
Seiji Miyake
Dai Inaya
Hiroyuki Uchida
Daisuke Kaida

Application Number:

JP2017181752A

Publication Date:

February 10, 2022

Filing Date:

September 21, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

National University Corporation Fukui University
National University Corporation Toyama University

International Classes:

A61K31/4184; A61K31/165; A61K31/437; A61K31/4965; A61K31/5377; A61P27/12

Foreign References:

WO2017017253A1

Other References:

Molecular Vision,2010年,Vol.16,pp.2626-2633
CANCER RESEARCH,1999年,Vol.59,pp.4375-4382

Attorney, Agent or Firm:

Patent business corporation HARAKENZO WORLD PATENT & TRADEMARK

Previous Patent: Video data sharing system, video data sharing program, video data sharing method and video data shar...

Next Patent: Light source device